Biodesix Inc
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| – | +6.6% | +190.8% | -37.1% | +22.1% | +6.7% | -1.9% | -10.0% | |
| – | +28.1% | +578.3% | -49.4% | +22.3% | -25.6% | -0.5% | -17.6% | |
| – | -10.6% | +1,075.3% | -47.3% | +31.7% | -39.0% | -0.1% | -27.7% | |
| – | -10.6% | +1,075.3% | -47.3% | +31.7% | -39.0% | -0.1% | -27.7% | |
| – | +179.7% | +189.2% | -76.1% | +38.5% | +51.6% | +12.0% | +5.0% | |
| – | +14.3% | +300.0% | -9.4% | -51.7% | +0.0% | – | – | |
| – | +52.7% | +49.9% | +31.5% | +111.1% | – | – | – | |
| – | +7.7% | +29.2% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | |
| – | -10.4% | -12.1% | -12.4% | -15.7% | -19.3% | -25.7% | -33.9% | |
| – | +14.0% | -70.4% | -29.5% | +28.3% | +30.7% | -19.2% | +17.8% | |
| – | +405.8% | +42.1% | -9.9% | -21.1% | +46.3% | -57.2% | +21.8% | |
| – | – | -2.6% | -99.8% | +8,278.9% | -81.0% | +144.2% | +85.1% | |
| – | +93.8% | +422.1% | -81.5% | +1.4% | +73.8% | -25.1% | +40.4% | |
| – | +3.1% | -33.1% | -37.3% | +150.2% | +40.9% | +3.4% | +30.3% | |
| – | – | – | -52.1% | +4.5% | -77.8% | +355.8% | -111.8% | |
| – | – | – | – | – | – | – | – | |
| – | +0.1% | +0.0% | +3.0% | +53.9% | +95.0% | +57.9% | +16.5% |
Data as of: September 28, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.